Role of Bradykinin in Preconditioning and Protection of the Ischaemic Myocardium

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2002 Feb 28

PMID 11861312

Citations 25

Authors

G F Baxter

Z Ebrahim

Affiliations

Soon will be listed here.

Citing Articles

Vitamin C Deficiency Exacerbates Dysfunction of Atherosclerotic Coronary Arteries in Guinea Pigs Fed a High-Fat Diet.

Skovsted G, Skat-Rordam J, Frokiaer A, Jensen H, Tveden-Nyborg P, Lykkesfeldt J Antioxidants (Basel). 2022; 11(11).

PMID: 36421412 PMC: 9686655. DOI: 10.3390/antiox11112226.

Implications of the Essential Role of Small Molecule Ligand Binding Pockets in Protein-Protein Interactions.

Skolnick J, Zhou H J Phys Chem B. 2022; 126(36):6853-6867.

PMID: 36044742 PMC: 9484464. DOI: 10.1021/acs.jpcb.2c04525.

A Potent Inhibitor of Aminopeptidase P2 Reduces Reperfusion Injury in Models of Myocardial Infarction and Stroke.

Lenz M, Tsai S, Roessler A, Wang Y, Sethupathi P, Jones W J Pharmacol Exp Ther. 2022; 380(3):220-229.

PMID: 34980660 PMC: 11046727. DOI: 10.1124/jpet.121.000875.

The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration.

Wang Y, Wang S, Lei M, Boyett M, Tsui H, Liu W Br J Pharmacol. 2017; 175(8):1362-1374.

PMID: 28574147 PMC: 5867015. DOI: 10.1111/bph.13872.

Comparison of endothelial function improvement estimated with reactive hyperemia index between ramipril and telmisartan in hypertensive patients.

Ki Y, Seo J, Kim H, Lim W, Seo H, Lee J Clin Hypertens. 2017; 23:4.

PMID: 28228970 PMC: 5309991. DOI: 10.1186/s40885-016-0060-y.

References

ROCHA e SILVA M, BERALDO W, ROSENFELD G . Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol. 1949; 156(2):261-73. DOI: 10.1152/ajplegacy.1949.156.2.261. View

Kositprapa C, Ockaili R, Kukreja R . Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart. J Mol Cell Cardiol. 2001; 33(7):1355-62. DOI: 10.1006/jmcc.2000.1396. View

TAKAGI G, Kiuchi K, Endo T, Yamamoto T, Sato N, Nejima J . Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J Cardiovasc Pharmacol. 2000; 36(1):22-30. DOI: 10.1097/00005344-200007000-00003. View

Baxter G, Marber M, Patel V, Yellon D . Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation. 1994; 90(6):2993-3000. DOI: 10.1161/01.cir.90.6.2993. View

Asher J, Naftilan A . Vasopeptidase inhibition: a new direction in cardiovascular treatment. Curr Hypertens Rep. 2000; 2(4):384-91. DOI: 10.1007/s11906-000-0042-y. View

Hassanabad Z, Furman B, Parratt J, Aughey E . Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts. Basic Res Cardiol. 1998; 93(4):241-9. DOI: 10.1007/s003950050091. View

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000; 342(3):145-53. DOI: 10.1056/NEJM200001203420301. View

Ozaki J, Shimizu H, Hashimoto Y, Itoh H, Nakao K, Inui K . Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides. Eur J Pharmacol. 1999; 370(3):307-12. DOI: 10.1016/s0014-2999(99)00115-6. View

Birincioglu M, Aksoy T, Olmez E, Acet A . Protective effect of ACE inhibitors on ischemia-reperfusion-induced arrhythmias in rats: is this effect related to the free radical scavenging action of these drugs?. Free Radic Res. 1998; 27(4):389-96. DOI: 10.3109/10715769709065778. View

10.

Bouchard J, Dumont E, Lamontagne D . Evidence that prostaglandins I2, E2, and D2 may activate ATP sensitive potassium channels in the isolated rat heart. Cardiovasc Res. 1994; 28(6):901-5. DOI: 10.1093/cvr/28.6.901. View

11.

Schultz J, Gross G . Opioids and cardioprotection. Pharmacol Ther. 2001; 89(2):123-37. DOI: 10.1016/s0163-7258(00)00106-6. View

12.

Yang X, Liu Y, Peterson E, Carretero O . Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury: the role of kinins. J Cardiovasc Pharmacol. 1997; 29(2):250-6. DOI: 10.1097/00005344-199702000-00014. View

13.

Ertl G, Kloner R, Alexander R, Braunwald E . Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation. 1982; 65(1):40-8. DOI: 10.1161/01.cir.65.1.40. View

14.

Stewart J, Vavrek R, Hassid A . Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells. Am J Physiol. 1987; 253(4 Pt 1):C588-98. DOI: 10.1152/ajpcell.1987.253.4.C588. View

15.

Tobe T, DE LANGEN C, Tio R, Bel K, Mook P, Wesseling H . In vivo effect of bradykinin during ischemia and reperfusion: improved electrical stability two weeks after myocardial infarction in the pig. J Cardiovasc Pharmacol. 1991; 17(4):600-7. DOI: 10.1097/00005344-199104000-00012. View

16.

Bouchard J, CHOUINARD J, Lamontagne D . Role of kinins in the endothelial protective effect of ischaemic preconditioning. Br J Pharmacol. 1998; 123(3):413-20. PMC: 1565180. DOI: 10.1038/sj.bjp.0701619. View

17.

Wirth K, Linz W, Wiemer G, Scholkens B . Kinins and cardioprotection. Pharmacol Res. 1997; 35(6):527-30. DOI: 10.1006/phrs.1997.0181. View

18.

Ahmad M, Zeitlin I, Parratt J . The release of kininase from rat isolated hearts during myocardial ischaemia. Immunopharmacology. 1996; 33(1-3):299-300. DOI: 10.1016/0162-3109(96)00047-1. View

19.

Anderson B, Khaper N, Dhalla A, Singal P . Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts. Can J Cardiol. 1996; 12(10):1099-104. View

20.

Chahine R, Adam A, Yamaguchi N, Gaspo R, Regoli D, Nadeau R . Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor. Br J Pharmacol. 1993; 108(2):318-22. PMC: 1907997. DOI: 10.1111/j.1476-5381.1993.tb12802.x. View